Zhaoxia Wang Selected Research

MELAS Syndrome (Syndrome, MELAS)

1/2021	Identification of a Novel Variant in MT-CO3 Causing MELAS.
1/2020	Patients with MELAS with negative myopathology for characteristic ragged-red fibers.
1/2020	RNA-seq profiling, and impaired autophagic process in skeletal muscle of MELAS.
1/2019	Appendicular skeletal muscle mass: A more sensitive biomarker of disease severity than BMI in adults with mitochondrial diseases.
4/2015	The mitochondrial DNA 10197 G > A mutation causes MELAS/Leigh overlap syndrome presenting with acute auditory agnosia.
1/2013	Quantitative measurement of cerebral oxygen extraction fraction using MRI in patients with MELAS.
12/2012	MR evaluation of cerebral oxygen metabolism and blood flow in stroke-like episodes of MELAS.
11/2011	Mutations in mitochondrially encoded complex I enzyme as the second common cause in a cohort of Chinese patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes.
12/2010	Phenotypic patterns of MELAS/LS overlap syndrome associated with m.13513G>A mutation, and neuropathological findings in one autopsy case.
3/2009	Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhaoxia Wang Research Topics

Disease

55	Neoplasms (Cancer) 06/2022 - 01/2010
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 06/2012
12	MELAS Syndrome (Syndrome, MELAS) 01/2021 - 07/2002
9	Muscular Diseases (Myopathy) 01/2022 - 04/2014
8	Inflammation (Inflammations) 09/2022 - 01/2010
8	Adenocarcinoma of Lung 01/2021 - 04/2006
8	Carcinogenesis 01/2021 - 02/2013
7	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2014
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2016
6	Hepatocellular Carcinoma (Hepatoma) 08/2019 - 05/2014
6	Colorectal Neoplasms (Colorectal Cancer) 10/2017 - 10/2011
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2013
5	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2019
5	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 05/2013
5	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 01/2019 - 07/2002
5	Stroke (Strokes) 01/2019 - 12/2010
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
4	Breast Neoplasms (Breast Cancer) 04/2019 - 02/2013
3	Neuronal intranuclear inclusion disease 01/2022 - 11/2019
3	Hypertension (High Blood Pressure) 01/2022 - 03/2016
3	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 05/2013
3	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2022 - 08/2013
3	Multiple System Atrophy 01/2022 - 01/2021
3	Hypoxia (Hypoxemia) 12/2021 - 05/2014
3	Myopathy with Abnormal Lipid Metabolism 12/2020 - 02/2014
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 04/2014
3	Muscular Dystrophies (Muscular Dystrophy) 11/2019 - 04/2014
3	Carcinoma (Carcinomatosis) 10/2019 - 01/2010
3	Adenocarcinoma 07/2019 - 11/2013
3	Obesity 08/2015 - 01/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 05/2015
2	Sarcoglycanopathies 01/2022 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 11/2020
2	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 01/2022 - 01/2021
2	Oculopharyngodistal Myopathy 01/2022 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Myocardial Infarction 09/2021 - 06/2021
2	Ischemic Stroke 09/2021 - 03/2009
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 03/2021 - 01/2021
2	Type 2K Charcot-Marie-Tooth disease 01/2021 - 08/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2019
2	Neuroinflammatory Diseases 01/2021 - 01/2019
2	Polyneuropathies (Polyneuropathy) 01/2021 - 01/2017
2	Muscle Weakness 12/2020 - 11/2020

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 09/2022 - 04/2011
22	Long Noncoding RNAIBA 03/2022 - 01/2013
13	Mitochondrial DNA (mtDNA)IBA 09/2022 - 07/2002
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
10	Biological ProductsIBA 06/2022 - 01/2013
9	CytokinesIBA 09/2022 - 01/2010
9	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2006
9	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
7	AntibodiesIBA 03/2021 - 07/2006
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 01/2010
6	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2016
5	Oxygen (Dioxygen)IBA 12/2021 - 12/2012
5	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2014
5	Peptides (Polypeptides)IBA 12/2017 - 01/2010
4	Gefitinib (Iressa)FDA Link 03/2022 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2014
3	ChromatinIBA 06/2022 - 01/2013
3	Small Nucleolar RNA (snoRNA)IBA 03/2022 - 10/2017
3	5' Untranslated Regions (5' UTR)IBA 01/2022 - 11/2019
3	Prealbumin (Transthyretin)IBA 01/2022 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 11/2012
3	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2020 - 02/2014
3	Tyrosine Kinase InhibitorsIBA 10/2020 - 01/2014
3	Signal Recognition ParticleIBA 01/2020 - 04/2014
3	Nicotine FDA Link 04/2019 - 02/2006
3	Messenger RNA (mRNA)IBA 01/2019 - 11/2013
3	NucleotidesIBA 01/2018 - 02/2007
3	IntegrinsIBA 12/2017 - 02/2016
3	Advanced Glycation End ProductsIBA 08/2017 - 01/2012
3	EnzymesIBA 12/2016 - 11/2011
3	LipidsIBA 12/2015 - 02/2007
3	Scorpion Venoms (Scorpion Venom)IBA 07/2011 - 01/2010
2	polyglycineIBA 01/2022 - 01/2021
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 04/2014
2	Sarcoglycans (beta Sarcoglycan)IBA 01/2022 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2016
2	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2020
2	Contrast MediaIBA 12/2021 - 05/2019
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2019
2	Angiotensin IIIBA 01/2021 - 03/2016
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2016
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2020 - 05/2014
2	Immunologic Factors (Immunomodulators)IBA 11/2020 - 09/2020
2	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2020
2	Docetaxel (Taxotere)FDA Link 05/2020 - 01/2010
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2020 - 01/2010
2	TensinsIBA 01/2020 - 05/2014
2	AntioxidantsIBA 01/2020 - 01/2018
2	Competitive Endogenous RNAIBA 01/2020 - 01/2018
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 05/2014

Therapy/Procedure

21	Therapeutics 06/2022 - 11/2012
11	Drug Therapy (Chemotherapy) 01/2021 - 01/2010
2	Immunotherapy 11/2021 - 10/2019
2	Precision Medicine 10/2019 - 10/2016